MEDEZE pushes Thai research for global competition, highlights "ATMP Sandbox".

Post Today•Economy•1d ago

Reader Briefing

MEDEZE advocates for government support of Thai research and innovation, particularly the ATMP Sandbox project, while outlining ambitious expansion and financial targets for 2026 and beyond.

•MEDEZE is calling on the new Thai government to prioritize and support domestic research and innovation, especially in the health sector.
•The ATMP Sandbox project is identified as a crucial initiative that enhances the global competitiveness of Thai companies.
•MEDEZE projects significant business growth for 2026, including international expansion into the Philippines and Mongolia, and aims to develop new stem cell therapies.
•Looking further ahead, MEDEZE targets substantial revenue and profit growth by 2028 and 2030, supported by strategic investments and partnerships.

Overview

•Dr. Wasawat Soytong of MEDEZE stated that the ATMP Sandbox project is very good, supporting Thai companies for global competition.
•MEDEZE believes Thailand needs to focus more on domestic drug research rather than just imports to compete globally.
•In 2026, MEDEZE anticipates business improvement with expansion in the Philippines and signing a contract with Mongolia.
•MEDEZE plans to register and develop new "stem cell drugs" expected for public use within this year.
•MEDEZE targets 25% growth in 2026, with a projected investment budget of 120-130 million Baht.
•MEDEZE is forming a joint venture with the Government Pharmaceutical Organization (GPO) and partners to produce cell culture media.
•MEDEZE aims for revenue growth of 300% and profit growth of 200% within three years by 2028.
•MEDEZE anticipates revenue to increase by over 700% to more than 4,500 million Baht and profit to grow by approximately 465% to 1,358 million Baht by 2030.

Full article content is available on the original source.

Read on Post Today (Thai Version)View in Google Translate

Source: Post Today (Original)

Key Quotes

Dr. Wasawat Soytong

"I see the ATMP Sandbox project as very good because it supports Thai companies to be ready and capable enough to compete effectively on a global scale."

ผมมองว่าโครงการ ATMP Sandbox ที่เคยทำมานั้นดีมาก เพราะเป็นการช่วยสนับสนุนให้บริษัทของคนไทยมีความพร้อมและมีศักยภาพเพียงพอที่จะออกไป แข่งขันในระดับโลก ได้อย่างมีประสิทธิภาพ

Dr. Veeravol Kemarungsan

"MEDEZE aims to operate in 2026, expecting 25% growth, and this year will be one of clear strategic elevation for MEDEZE."

เมดีซฯตั้งเป้าหมายการดำเนินงานในปี 2026 โดยคาดว่าจะเติบโตที่ระดับ 25% และเป็นปีแห่งการยกระดับเชิงกลยุทธ์ของ MEDEZE อย่างชัดเจน

Key Entities

Organization

MEDEZE

A company that is urging the Thai government to support domestic research and innovation, with ambitious growth plans in the health and biopharma sectors.

Government Pharmaceutical Organization (GPO)(องค์การเภสัชกรรม)

A Thai state-owned enterprise that MEDEZE is strategically investing with to establish a joint venture for cell culture media production.

Stock Exchange of Thailand(ตลาดหลักทรัพย์แห่งประเทศไทย)ℹ️

An organization that supports the JUMP+ project, which MEDEZE is participating in to improve its business strategy, finance, and governance.

Person

Dr. Wasawat Soytong(นายแพทย์วสวัตติ์ สร้อยทอง)

Investor Relations at MEDEZE Group, who expressed his vision for government support and highlighted the ATMP Sandbox project.

Dr. Veeravol Kemarungsan(นายแพทย์วีรพล เขมะรังสรรค์)

Chief Executive Officer of MEDEZE Group, who outlined the company's operational goals and strategic direction for 2026.

Place

Philippines(ประเทศฟิลิปปินส์)ℹ️

A country where MEDEZE is expanding its business through a franchise model, as part of its international growth strategy.

Mongolia(มองโกเลีย)ℹ️

A country with which MEDEZE plans to sign a contract in 2026 as part of its ongoing international expansion.

Law

Stem cell drugs(ยาเสตมเซลล์)

New drugs that MEDEZE is developing and plans to register, which are expected to be available for use within the year.